IQVIA

IQVIA is a global provider of advanced analytics, technology solutions and contract research services to the life sciences and healthcare sectors. The company combines clinical development services (CRO), real-world evidence and commercial analytics to support pharmaceutical, biotechnology and medical device companies, as well as payers, providers and government agencies. Formed through the 2016 merger of Quintiles and IMS Health and rebranded as IQVIA in 2017, the firm is headquartered in Durham, North Carolina and operates across more than 100 countries with a workforce of over 80,000 employees. IQVIA is publicly traded on the New York Stock Exchange (IQV) and generates multi‑billion dollar annual revenues derived from services, software and data licensing. Positioned as a major global player in life sciences services and healthcare data analytics, IQVIA differentiates itself by combining large proprietary healthcare datasets with clinical trial operations and cloud-based technology platforms to enable real‑world evidence generation, trial acceleration and commercial insights. The company serves a broad roster of pharmaceutical and biotech clients and collaborates with health systems and public-sector organizations; its growth strategy emphasizes strategic acquisitions, technology investment and partnerships to expand analytics and AI-driven capabilities. Recent initiatives focus on scaling cloud-native platforms, real-world data and AI analytics to support precision medicine, regulatory evidence generation and faster clinical development.